Search Legislation

National Health Service Act 2006

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As enacted)
 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

Changes over time for: Cross Heading: Pharmaceutical remuneration to be apportioned among integrated care boards

 Help about opening options

Changes to legislation:

National Health Service Act 2006, Cross Heading: Pharmaceutical remuneration to be apportioned among integrated care boards is up to date with all changes known to be in force on or before 27 February 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations. Help about Changes to Legislation

[F1Pharmaceutical remuneration to be apportioned among [F2integrated care boards]E+W

2(1)[F3NHS England] must determine the elements of pharmaceutical remuneration in respect of which apportionments are to be made in relation to a financial year in accordance with this paragraph.E+W

(2)In this Schedule, those elements of pharmaceutical remuneration are referred to as “designated elements”.

(3)[F3NHS England] must notify each [F4integrated care board] of a determination under sub-paragraph (1).

(4)[F3NHS England] must apportion the sums paid by it in respect of each designated element during the financial year among all [F5integrated care boards], in such manner as [F3NHS England] thinks appropriate.

(5)In apportioning sums under sub-paragraph (4), [F3NHS England] may, in particular, take into account the financial consequences of orders for the provision of drugs that are attributable to the members of each [F6integrated care board].

(6)Where an amount of pharmaceutical remuneration is apportioned to [F7an integrated care board], [F3NHS England]

(a)may deduct that amount from the sums that it would otherwise pay to [F8the board] under section 223G(1), and

(b)if it does so, must notify [F9the board] accordingly.

(7)The Secretary of State may direct [F3NHS England] that an element of pharmaceutical remuneration specified in the direction is not to be included in a determination under sub-paragraph (1).

(8)In determining the amount to be allotted to [F10an integrated care board] for the purposes of section 223G, [F3NHS England] must take into account the effect of this Schedule.

[F11(9)For the purposes of sections 223GC and 223M(1)(b) and paragraph 22 of Schedule 1B, any amount of which an integrated care board is notified under sub-paragraph (6) is to be treated as expenditure of the group which is attributable to the performance by it of its functions in the year in question.]]

Textual Amendments

Back to top

Options/Help